Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29943905

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2018 Oct
First author
Mogensen SS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mogensen SS
      type
      Author
    2. name
      Harila-Saari A
      type
      Author
    3. name
      Mäkitie O
      type
      Author
    4. name
      Myrberg IH
      type
      Author
    5. name
      Niinimäki R
      type
      Author
    6. name
      Vestli A
      type
      Author
    7. name
      Hafsteinsdottir S
      type
      Author
    8. name
      Griškevicius L
      type
      Author
    9. name
      Saks K
      type
      Author
    10. name
      Hallböök H
      type
      Author
    11. name
      Retpen J
      type
      Author
    12. name
      Helt LR
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mogensen SS
      type
      Author
    2. name
      Harila-Saari A
      type
      Author
    3. name
      Mäkitie O
      type
      Author
    4. name
      Myrberg IH
      type
      Author
    5. name
      Niinimäki R
      type
      Author
    6. name
      Vestli A
      type
      Author
    7. name
      Hafsteinsdottir S
      type
      Author
    8. name
      Griškevicius L
      type
      Author
    9. name
      Saks K
      type
      Author
    10. name
      Hallböök H
      type
      Author
    11. name
      Retpen J
      type
      Author
    12. name
      Helt LR
      type
      Author
    bibliography ids
    1. nci-bib-dc38d3f5cbc9655faf07e5f8
    book metadata
    content sha256
    afa534217e5172c7c2d0ec358d56f2567c58fcb921727738236797f3f2329249
    document type
    citation
    dois
    1. 10.1002/pbc.27300
    electronic publication date
    display
    2018 Jun 26
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29943905
    immutable id
    pubmed:29943905@afa534217e5172c7c2d0ec358d56f2567c58fcb921727738236797f3f2329249
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    10
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e27300
    volume
    65
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29943905
      provenance
      batch id
      c4c0356d060413f719c2
      provider
      NCBI PubMed ESummary
      record sha256
      bcce31560a3dd5ff30692fd68dbc6bb45251fe71918d258e08dde04cc15ae945
      response sha256
      adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
      retrieved at
      2026-09-09T23:47:33.674758+00:00
      publication date
      display
      2018 Oct
      precision
      month
      year
      2018
      publication types
      1. Comparative Study
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29943905/
      title
      Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.

      Preserved source evidence · Not medical advice